- Advertisement -
Swiss pharma giant Vifor, speculated as a takeover target by CSL, has a strong presence in Australia and is gunning to develop a suite of new treatments for kidney disease.
Media speculation was rife at the end of last week that CSL was in advanced talks with Vifor Pharma about a $10 billion…
